Table 3.
Outcomes of primary/secondary M2 patients treated with the ONE-SEG technique.
All | Primary M2 | Secondary M2 | |
---|---|---|---|
Number of patients, n (%) | 30 (100) | 17 (56.7) | 13 (43.3) |
Outcome | |||
Procedural outcome | |||
Number of passes, median (IQR) | 2 (1–3) | 2 (1–3) | 2 (1–2.5) |
First-pass eTICI score 2c/3, n (%) | 6 (20) | 3 (17.7) | 3 (23.1) |
First-pass eTICI score 2b/2c/3, n (%) | 12 (40) | 7 (41.2) | 5 (38.5) |
Final eTICI score 2c/3, n (%) | 22 (73.3) | 12 (70.6) | 10 (70.9) |
Final eTICI score 2b/2c/3, n (%) | 27 (90) | 15 (88.2) | 12 (92.3) |
Safety outcome | |||
Any ICH, n (%) | 5 (16.7) | 3 (17.7) | 2 (15.4) |
Symptomatic ICH, n (%) | 1 (3.3) | 0 (0) | 1 (7.7) |
Parenchymal hematoma, n (%) | 2 (6.7) | 0 (0) | 2 (15.4) |
Subarachnoid hemorrhage, n (%) | 0 (0) | 0 (0) | 0 (0) |
Extravasation, n (%) | 0 (0) | 0 (0) | 0 (0) |
Spasm, n (%) | 1 (3.3) | 1 (5.9) | 0 (0) |
Embolization to distal territory, n (%) | 1 (3.3) | 1 (5.9) | 0 (0) |
Embolization to new territory, n (%) | 0 (0) | 0 (0) | 0 (0) |
Mortality at 90 days, n (%) | 2 (6.7) | 1 (5.9) | 1 (7.7) |
Efficacy outcome | |||
mRS score at discharge, median (IQR) | 3 (1–4) | 2 (0.5–3) | 4 (3–4.5) |
mRS score 0–2 at discharge, n (%) | 13 (43.3) | 11 (64.7) | 2 (15.4) |
mRS score 0–3 at discharge, n (%) | 18 (60) | 14 (82.4) | 4 (30.8) |
mRS score at 3 months, median (IQR) | 3 (1–4) | 1 (0–3) | 3 (2.5–4.5) |
mRS score 0–2 at 3 months, n (%) | 14 (46.7) | 11 (64.7) | 3 (23.1) |
mRS score 0–3 at 3 months, n (%) | 22 (73.3) | 15 (88.2) | 7 (53.9) |
Data are presented as number (%) or median (interquartile range) values.
eTICI, expanded Thrombolysis in Cerebral Infarction; ICH, intracranial hemorrhage; mRS, modified Rankin Scale; ONE-SEG technique, combining the deployment of only the distal basket segment of the EMBOTRAP III and aspiration catheter. Bold values in Primary M2, M2 occlusion that occurred de novo; Secondary M2, M2 occlusion from occlusion of a large vessel due to migration or fragmentation of a thrombus.